Trials / Completed
CompletedNCT01233570
Topical Tacrolimus 0.1% Ointment For Treatment Of Cutaneous Crohn's Disease
Topical Tacrolimus 0.1% Ointment for Treatment of Cutaneous Crohn's Disease
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- University of Aberdeen · Academic / Other
- Sex
- All
- Age
- 12 Years
- Healthy volunteers
- Not accepted
Summary
An assessment of the efficacy of topical tacrolimus in the treatment of cutaneous crohns disease
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Tacrolimus | Once daily application for 12 weeks followed by 4 weeks observation. Optional 36 week open label extension |
Timeline
- First posted
- 2010-11-03
- Last updated
- 2010-11-03
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT01233570. Inclusion in this directory is not an endorsement.